These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3434758)

  • 21. The onset of alcuronium and tubocurarine: alone and in combination.
    Roberts SP; Pollard BJ
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):195-8. PubMed ID: 8383403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of neuromuscular block in the diaphragm and hand after administration of tubocurarine, pancuronium and alcuronium.
    Derrington MC; Hindocha N
    Br J Anaesth; 1990 Mar; 64(3):294-9. PubMed ID: 2328177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atracurium--increased duration of its effect following alcuronium].
    Janda A; Mühlsteiger B; Schwarz S
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):203-5. PubMed ID: 2393076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular effects of alcuronium chloride (Dialferin) and pancuronium bromide in children (author's transl)].
    Negishi T; Kitamura S; Tashiro C; Oka N; Tosaki Y
    Masui; 1980 May; 29(5):449-57. PubMed ID: 7401288
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation of the neuromuscular blockade produced by alcuronium with halothane, enflurane and isoflurane.
    Keens SJ; Hunter JM; Snowdon SL; Utting JE
    Br J Anaesth; 1987 Aug; 59(8):1011-6. PubMed ID: 3651269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response curves for alcuronium and pancuronium alone and in combination.
    Shanks CA
    Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of respiration following neuromuscular blockade with atracurium and alcuronium.
    Astley BA; Hackett H; Hughes R; Payne JP
    Br J Anaesth; 1986; 58 Suppl 1():75S-79S. PubMed ID: 3754758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of halothane on the action of alcuronium in the dog.
    Jones RS; Heckmann R; Wuersch W
    Experientia; 1979 Sep; 35(9):1209-10. PubMed ID: 226397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe bronchospasm in an asthmatic patient following alcuronium and D-tubocurarine.
    Yeung ML; Ng LY; Koo AW
    Anaesth Intensive Care; 1979 Feb; 7(1):62-4. PubMed ID: 434447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of alcuronium in patients undergoing renal transplantation.
    Kaushik S; Grover VK; Singh H; Yadav RV
    Br J Anaesth; 1984 Nov; 56(11):1229-33. PubMed ID: 6386020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prior administration of suxamethonium on non-depolarising muscle relaxants in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 Jan; 36(1):43-7. PubMed ID: 6709976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haemodilution and duration of action of muscle relaxants (author's transl)].
    Schuh FT
    Anaesthesist; 1981 Jan; 30(1):44-5. PubMed ID: 7469004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcuronium pharmacodynamics in dogs: effect-concentration relationships in the diaphragmatic and limb muscles.
    Walker JS; Shanks CA; Borton C; Brown KF
    J Pharm Pharmacol; 1987 Aug; 39(8):614-20. PubMed ID: 2888852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-depolarizing neuromuscular blockers and the eye: a study of intraocular pressure. Pancuronium versus alcuronium.
    George R; Nursingh A; Downing JW; Welsh NH
    Br J Anaesth; 1979 Aug; 51(8):789-92. PubMed ID: 497077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Online parameter estimation and control of d-tubocurarine-induced muscle relaxation.
    Rametti LB; Bradlow HS; Uys PC
    Med Biol Eng Comput; 1985 Nov; 23(6):556-64. PubMed ID: 3908841
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on the neuromuscular blocking action of alcuronium in the dog and its reversal by neostigmine.
    Jones RS; Heckmann R; Wuersch W
    Res Vet Sci; 1978 Jul; 25(1):101-2. PubMed ID: 212797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?
    Brown TC; Meretoja OA; Clare D; Bell B
    Anaesth Intensive Care; 1990 Nov; 18(4):479-82. PubMed ID: 2268013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical research of muscular relaxation induced by alcuronium and pancuronium].
    Gong Z; Ye T; Pei L; Luo X; Luo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):301-4. PubMed ID: 8575054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocarbia and muscle relaxant plasma levels.
    Lamont AS; Roberts MS; McLeod LJ
    Anaesth Intensive Care; 1987 Aug; 15(3):354-5. PubMed ID: 3116880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.